Discontent is growing over new drug pricing re-evaluation system
Published: 2002-09-24 06:59:00
Updated: 2002-09-24 06:59:00
The government's projected enforcement over the new drug pricing re-evaluation system has overshadowed the domestic pharmaceutical industry with no some proper countermeasures foreseeable, while raising their mounting discontent over the new system.
1) Aftereffects
Pharmaceutical business ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
